TY - JOUR
T1 - Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3
AU - de las Rivas, Matilde
AU - Paul Daniel, Earnest James
AU - Narimatsu, Yoshiki
AU - Compañón, Ismael
AU - Kato, Kentaro
AU - Hermosilla, Pablo
AU - Thureau, Aurélien
AU - Ceballos-Laita, Laura
AU - Coelho, Helena
AU - Bernadó, Pau
AU - Marcelo, Filipa
AU - Hansen, Lars
AU - Maeda, Ryota
AU - Lostao, Anabel
AU - Corzana, Francisco
AU - Clausen, Henrik
AU - Gerken, Thomas A.
AU - Hurtado-Guerrero, Ramon
N1 - info:eu-repo/grantAgreement/FCT/5876/147258/PT#
FEDER (grant no. 2014-2020)
National Institutes of Health GM113534-01S.
Seventh Framework Programme - 283570, BIOSTRUCTX_5186.
Danmarks Grundforskningsfond - E34_R17.
ARAID, MEC (grant no. CTQ2013-44367-C2-2-P, BFU2016-75633-P and RTI2018-099592-B-C21).
FCT-Portugal for IF Investigator (IF/00780/2015), PTDC/BIA-MIB/31028/2017 and UID/Multi/04378/2019.
PTNMR (grant no. ROTEIRO/0031/2013 and PINFRA/22161/2016).
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Polypeptide GalNAc-transferase T3 (GalNAc-T3) regulates fibroblast growth factor 23 (FGF23) by O-glycosylating Thr178 in a furin proprotein processing motif RHT178R↓S. FGF23 regulates phosphate homeostasis and deficiency in GALNT3 or FGF23 results in hyperphosphatemia and familial tumoral calcinosis. We explored the molecular mechanism for GalNAc-T3 glycosylation of FGF23 using engineered cell models and biophysical studies including kinetics, molecular dynamics and X-ray crystallography of GalNAc-T3 complexed to glycopeptide substrates. GalNAc-T3 uses a lectin domain mediated mechanism to glycosylate Thr178 requiring previous glycosylation at Thr171. Notably, Thr178 is a poor substrate site with limiting glycosylation due to substrate clashes leading to destabilization of the catalytic domain flexible loop. We suggest GalNAc-T3 specificity for FGF23 and its ability to control circulating levels of intact FGF23 is achieved by FGF23 being a poor substrate. GalNAc-T3’s structure further reveals the molecular bases for reported disease-causing mutations. Our findings provide an insight into how GalNAc-T isoenzymes achieve isoenzyme-specific nonredundant functions.
AB - Polypeptide GalNAc-transferase T3 (GalNAc-T3) regulates fibroblast growth factor 23 (FGF23) by O-glycosylating Thr178 in a furin proprotein processing motif RHT178R↓S. FGF23 regulates phosphate homeostasis and deficiency in GALNT3 or FGF23 results in hyperphosphatemia and familial tumoral calcinosis. We explored the molecular mechanism for GalNAc-T3 glycosylation of FGF23 using engineered cell models and biophysical studies including kinetics, molecular dynamics and X-ray crystallography of GalNAc-T3 complexed to glycopeptide substrates. GalNAc-T3 uses a lectin domain mediated mechanism to glycosylate Thr178 requiring previous glycosylation at Thr171. Notably, Thr178 is a poor substrate site with limiting glycosylation due to substrate clashes leading to destabilization of the catalytic domain flexible loop. We suggest GalNAc-T3 specificity for FGF23 and its ability to control circulating levels of intact FGF23 is achieved by FGF23 being a poor substrate. GalNAc-T3’s structure further reveals the molecular bases for reported disease-causing mutations. Our findings provide an insight into how GalNAc-T isoenzymes achieve isoenzyme-specific nonredundant functions.
UR - http://www.scopus.com/inward/record.url?scp=85078044367&partnerID=8YFLogxK
U2 - 10.1038/s41589-019-0444-x
DO - 10.1038/s41589-019-0444-x
M3 - Article
C2 - 31932717
AN - SCOPUS:85078044367
JO - Nature Chemical Biology
JF - Nature Chemical Biology
SN - 1552-4450
ER -